Pittsburgh, PA, United States of America

Michael J Passineau

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael J Passineau: Innovator in Pulmonary Vascular Research

Introduction

Michael J Passineau is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of pulmonary vascular research, particularly in the isolation and utilization of pulmonary arterial endothelial cells. With a total of 2 patents, his work is paving the way for personalized treatment options for patients suffering from pulmonary hypertension.

Latest Patents

Michael J Passineau's latest patents focus on the isolation of pulmonary arterial endothelial cells from patients with pulmonary vascular disease. The first patent provides methods for obtaining, recovering, and culturing these cells from individuals subjected to right heart catheterization. This process is crucial for diagnosing pulmonary hypertension. The isolated cells can be used to generate a cellular phenotyping profile, which allows for the development of personalized pharmacotherapy regimes. This innovation assists clinicians in tailoring treatment and prognosis for individual patients.

Career Highlights

Michael J Passineau is affiliated with the Allegheny-Singer Research Institute, where he continues to advance research in pulmonary vascular diseases. His work is instrumental in bridging the gap between clinical practice and innovative research, ultimately improving patient outcomes.

Collaborations

Some of his notable coworkers include Srinivas Murali and Raymond L Benza. Their collaborative efforts contribute to the ongoing research and development in the field of pulmonary health.

Conclusion

Michael J Passineau's innovative work in isolating pulmonary arterial endothelial cells represents a significant advancement in personalized medicine for pulmonary vascular diseases. His contributions are vital for improving treatment strategies and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…